News AstraZeneca changes contractors as HQ delayed again AstraZeneca has switched building contractors in a bid to hasten progress on its delayed and over-budget new headquarters, which is under construction in Cambridge.
News Serial entrepreneur Huntingdon raises funds for latest biote... Z Factor, a University of Cambridge spin-out company has raised £7 million in a Series A investment
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.